miR-29a attenuates cardiac hypertrophy through inhibition of PPARÎ´ expression.
Zhang, Si; Yin, Zhongnan; Dai, Fei-Fei; Wang, Hao; Zhou, Meng-Jiao; Yang, Ming-Hui; Zhang, Shu-Feng; Fu, Zhi-Feng; Mei, Ying-Wu; Zang, Ming-Xi; Xue, Lixiang.
J Cell Physiol
; 234(8): 13252-13262, 2019 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-30580435
Implication of microRNAs in atrial natriuretic peptide and nitric oxide signaling in vascular smooth muscle cells.
A cardiac microRNA governs systemic energy homeostasis by regulation of MED13.
Regulation of B-cell development and function by microRNAs.
MicroRNA regulation of unfolded protein response transcription factor XBP1 in the progression of cardiac hypertrophy and heart failure in vivo.
Targeting Peroxisome Proliferator Activated Receptor α (PPAR α) for the Prevention of Mitochondrial Impairment and Hypertrophy in Cardiomyocytes.
miR-218 Involvement in Cardiomyocyte Hypertrophy Is Likely through Targeting REST.
MiR-30e Attenuates Isoproterenol-induced Cardiac Fibrosis Through Suppressing Snai1/TGF-ß Signaling.
miR-23a functions downstream of NFATc3 to regulate cardiac hypertrophy.
The clinical potential of adipogenesis and obesity-related microRNAs.
Endoplasmic Reticulum Stress is Involved in DFMO Attenuating Isoproterenol-Induced Cardiac Hypertrophy in Rats.